Eastgate Biotech Corp
OTC:ETBI

Watchlist Manager
Eastgate Biotech Corp Logo
Eastgate Biotech Corp
OTC:ETBI
Watchlist
Price: 0.0008 USD Market Closed
Market Cap: $14.4m

Eastgate Biotech Corp
Investor Relations

Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2014-01-16. The firm produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The company utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The firm develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles).

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Ms. Rosella C. Perri
CEO, Secretary, Treasurer & Director
No Bio Available
Mr. William D. Abajian
Vice Chairman, President & COO
No Bio Available
Dr. Joseph Schwarz Ph.D.
Chief Scientific Officer
No Bio Available

Contacts

Address
UTAH
Salt Lake City
2681 E Parleys Way Ste 204
Contacts